… Volcano plots depicting features that are statistically significant in idiopathic pulmonary
fibrosis (IPF) lung tissue compared with control lung tissue at a false discovery rate <0.05 (blue …

… (miRNA) gene signatures as biomarkers in patients with Idiopathic pulmonary fibrosis (IPF), …
identify potential miRNA or gene signatures to serve as novel biomarkers for survival in IPF …

… Therefore, we constructed a molecular genomic signature to predict the prognosis of IPF …
the performance of the genomic signature in the validation cohort. The signature showed an …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition with poor survival times. We
previously published a genome-… size estimates, we performed a genome-wide meta-analysis …

… This study explores a novel potential clinical marker suitable for IPF by constructing a
prognostic signature. We focused on the role of m7GRGs in IPF and constructed a novel m7GPS …

… nintedanib, for treatment of patients with idiopathic pulmonary fibrosis (IPF). However, neither
… minimal effect on IPF-specific gene signature or alter translational modifications involved in …

… translational biomarker studies. Transcriptomic and proteomic disease signatures generated
from clinically relevant human … ” modeling can enable translational disease understanding, …

… The pathogenic mechanisms leading to irreversible fibrosis are not fully understood;
however, advances in basic and translational research have identified new potential therapeutic …

… highly fibrotic lung regions, yet the genetic signature from fibroblasts in areas of active …
novel genomic signature with translational significance for human idiopathic pulmonary fibrosis…

… of fibrosis, most notably in idiopathic pulmonary fibrosis (IPF), the most rapidly progressive
and fatal of all fibrotic … In terms of the potential translational importance of these findings, …